The haploidentical option for high-risk haematological malignancies
- 29 February 2008
- journal article
- Published by Elsevier BV in Blood Cells, Molecules, and Diseases
- Vol. 40 (1), 8-12
- https://doi.org/10.1016/j.bcmd.2007.07.004
Abstract
No abstract availableKeywords
This publication has 14 references indexed in Scilit:
- Adult Recipients of Matched Related Donor Blood Cell Transplants Given Myeloablative Regimens Including Pretransplant Antithymocyte Globulin Have Lower Mortality Related to Graft-versus-Host Disease: A Matched Pair AnalysisTransplantation and Cellular Therapy, 2007
- Full Haplotype-Mismatched Hematopoietic Stem-Cell Transplantation: A Phase II Study in Patients With Acute Leukemia at High Risk of RelapseJournal of Clinical Oncology, 2005
- Effect of combined T‐ and B‐cell depletion of allogeneic HLA‐mismatched bone marrow graft on the magnitude and kinetics of Epstein–Barr virus load in the peripheral blood of bone marrow transplant recipientsClinical Transplantation, 2004
- NK cells: a lesson from mismatched hematopoietic transplantationTrends in Immunology, 2002
- Effectiveness of Donor Natural Killer Cell Alloreactivity in Mismatched Hematopoietic TransplantsScience, 2002
- Increased incidence of EBV-associated lymphoproliferative disorders after allogeneic stem cell transplantation from matched unrelated donors due to a change of T cell depletion techniqueBone Marrow Transplantation, 2002
- Postgrafting administration of granulocyte colony-stimulating factor impairs functional immune recovery in recipients of human leukocyte antigen haplotype–mismatched hematopoietic transplantsBlood, 2001
- Role of Natural Killer Cell Alloreactivity in HLA-Mismatched Hematopoietic Stem Cell TransplantationBlood, 1999
- Treatment of High-Risk Acute Leukemia with T-Cell–Depleted Stem Cells from Related Donors with One Fully Mismatched HLA HaplotypeNew England Journal of Medicine, 1998
- Megadose of T cell-depleted bone marrow overcomes MHC barriers in sublethally irradiated miceNature Medicine, 1995